HNGE HNGE Business Segments — R&D
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by HNGE in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: HNGE’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about HNGE's business segments — r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is HNGE's business segments — R&D?
- HNGE (HNGE) reported business segments — R&D of $25.54M in Q1 2026.
- How has HNGE's business segments — R&D changed year-over-year?
- HNGE's business segments — R&D increased by 15.9% year-over-year, from $22.04M to $25.54M.
- What does business segments — R&D mean?
- Measures the investment in developing, maintaining, and improving the company's AI-powered motion tracking technology and clinical platform features. This spending is a primary driver of future innovation and competitive differentiation in the musculoskeletal health market. Investors monitor this to gauge the company's commitment to technological leadership and product evolution.